These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2253080)

  • 1. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
    Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF
    Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
    Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF
    J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
    Yunginger JW; Gleich GJ
    J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
    Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
    J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral immunotherapy with short ragweed extract.
    Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP
    Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal immunotherapy in pollen-sensitive children.
    Cserháti E; Mezei G
    Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Amodio FJ; Kagey-Sobotka A; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1982 Feb; 69(2):181-93. PubMed ID: 7056949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects.
    Winther L; Malling HJ; Mosbech H
    Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic problems before specific immunotherapy in patients with late-summer seasonal allergic rhinitis].
    Kadocsa E
    Orv Hetil; 1994 Sep; 135(36):1963-6. PubMed ID: 7936601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ragweed immunotherapy in adult asthma.
    Creticos PS; Reed CE; Norman PS; Khoury J; Adkinson NF; Buncher CR; Busse WW; Bush RK; Gadde J; Li JT
    N Engl J Med; 1996 Feb; 334(8):501-6. PubMed ID: 8559203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
    Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
    Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG and IgE antibody response following Pollinex-R immunotherapy.
    Ko HS; Chen SJ; Jaworska E
    Ann Allergy; 1987 Dec; 59(6):441-9. PubMed ID: 3122605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of weekly versus monthly ragweed allergen injections on immunological parameters.
    Fortner BR; Dantzler BS; Tipton WR; Nelson HS
    Ann Allergy; 1981 Sep; 47(3):147-50. PubMed ID: 7270985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and cellular changes accompanying the therapy of pollen allergy.
    Levy DA; Lichtenstein LM; Goldstein EO; Ishizaka K
    J Clin Invest; 1971 Feb; 50(2):360-9. PubMed ID: 4099843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
    Iliopoulos O; Proud D; Adkinson NF; Creticos PS; Norman PS; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    J Allergy Clin Immunol; 1991 Apr; 87(4):855-66. PubMed ID: 2013680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.